-

NYSE to Suspend Trading in Silvergate Capital Corporation (SI) and Commence Delisting Proceedings

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Silvergate Capital Corporation (the “Company”) from the NYSE. Trading in the Company’s Securities will be suspended immediately.

Symbol

Description

SI

Class A Common Stock, par value $0.01 per share

SI PRA

Depositary Shares, Each Representing a 1/40th Interest in a Share of 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A

NYSE Regulation halted trading in the Company’s Securities on May 10, 2023 and has now determined to commence delisting proceedings with respect to the Company pursuant to Section 802.01E of the NYSE Listed Company Manual. NYSE Regulation reached this delisting determination because the Company is currently delayed in filing with the Securities and Exchange Commission (the “SEC”) its fiscal year ended December 31, 2022 Form 10-K. On May 11, 2023, the Company filed a Form 8-K with the SEC disclosing that it is unable to complete this filing or its Form 10-Q for the quarter ended March 31, 2023 and does not expect to be able to file any quarterly reports on Form 10-Q or annual reports on Form 10-K for subsequent periods. As a result, the Company will not be able to cure the late filer delinquency by the maximum allowable trading period under Section 802.01E of the NYSE’s Listed Company Manual.

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the SEC to delist the Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

Contacts

Company Contact:
Investor Relations:
(858) 200-3782
investors@silvergate.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

NYSE Regulation


Release Versions

Contacts

Company Contact:
Investor Relations:
(858) 200-3782
investors@silvergate.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

More News From NYSE Regulation

NYSE Group Consolidated Short Interest Report

NEW YORK--(BUSINESS WIRE)--NYSE today reported short interest as of the close of business on the settlement date of December 15, 2025. SETTLEMENT DATE EXCHANGE TOTAL CURRENT SHORT INTEREST TOTAL PREVIOUS SHORT INTEREST (Revised) NUMBER of SECURITIES with a SHORT POSITION NUMBER of SECURITIES with a POSITION >= 5,000 SHARES 12/15/2025 NYSE 16,401,052,680 16,170,141,102 2,876 2,555 12/15/2025 NYSE ARCA 2,248,888,701 2,169,649,765 2,519 1,703 12/15/2025 NYSE AMERICAN 818,416,336 772,363,508 303...

NYSE to Commence Delisting Proceedings with Respect to Warrants of UWM Holdings Corporation (UWMC WS)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol UWMC WS — each warrant exercisable for one share of Class A common stock at an exercise price of $11.50 with an expiration date of January 21, 2026 of UWM Holdings Corporation (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Tr...

NYSE to Commence Delisting Proceedings with Respect to Warrants of Vicarious Surgical Inc. (RBOT WS)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol RBOT WS — thirty (30) whole warrants are exercisable to purchase one share of Class A common stock of Vicarious Surgical Inc. (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Trading in the Company’s Class A common stock — tick...
Back to Newsroom